Meeder Asset Management Inc X4 Pharmaceuticals, Inc Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$7.98 - $10.44 $3,790 - $4,959	-475 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.03 - $11.01 $2,864 - $5,229	475 New	475 $5,000
Q3 2019 Oct 17, 2019	SELL	$11.06 - $15.75 $2,267 - $3,228	-205 Closed	0 $0
Q2 2019 Aug 05, 2019	SELL	$12.57 - $21.67 $2,363 - $4,073	-188 Reduced 47.84%	205 $3,000
Q1 2019 Apr 16, 2019	BUY	$15.19 - $22.98 $5,969 - $9,031	393 New	393 $7,000

106

103M

206K

291K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $37.1M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.